Metraipolis › archive › dc_fb77d5fb1692
70 Years of DON and Beyond: Glutaminase Inhibition as a Synergistic Strategy in Cancer Combination Therapy — Europe PMC PMID:42514928
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42514928
- DOI
- 10.3390/pharmaceutics18070850
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T07:38:21.160Z
- SHA-256 of the archived text
d76caef615fdbe72e8fe6560ecd3ccd25d9201620652d6130104aabff3751a81- Stable URL of this page
https://metraipolis.com/documento/dc_fb77d5fb1692
How to cite
70 Years of DON and Beyond: Glutaminase Inhibition as a Synergistic Strategy in Cancer Combination Therapy — Europe PMC PMID:42514928 — Europe PMC (en), https://europepmc.org/article/MED/42514928 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb77d5fb1692 (Metraipolis archive dc_fb77d5fb1692, sha256 d76caef615fdbe72e8fe6560ecd3ccd25d9201620652d6130104aabff3751a81)
BibTeX
@misc{dcfb77d5fb1692,
title = {70 Years of DON and Beyond: Glutaminase Inhibition as a Synergistic Strategy in Cancer Combination Therapy — Europe PMC PMID:42514928},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42514928},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb77d5fb1692; sha256 d76caef615fdbe72e8fe6560ecd3ccd25d9201620652d6130104aabff3751a81},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42514928. Agents can read the archived copy with the MCP tool read_document.